New England Compounding Center, Framingham, MA

Is New England Compounding Center registered with the FDA as a 503B outsourcing facility?

No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.

Does New England Compounding Center hold a Massachusetts pharmacy license?

State board of pharmacy records for Massachusetts are not checked: the board’s website refused automated requests, and this index does not work around blocks. The Texas State Board of Pharmacy also lists nonresident license 22866 for NEW ENGLAND COMPOUNDING CENTER, FRAMINGHAM, MA, status Revocation, as of Nov 15, 2026. The Colorado State Board of Pharmacy also lists nonresident license OSP 5402 for New England Compounding Center, FRAMINGHAM, MA, status Surrendered, as of Nov 15, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054016977 for NEW ENGLAND COMPOUNDING CENTER, FRAMINGHAM, MA, status SUSPENDED and license 058013496 for NEW ENGLAND COMPOUNDING CENTER, FRAMINGHAM, MA, status CANCELLED, as of Nov 13, 2026.

Has New England Compounding Center had a state board action or FDA letter?

FDA letters: no matching record found on FDA’s compounding inspections and actions page (current as of Oct 22, 2026, covering 2019 on) on Nov 15, 2026; the page lists 1 other action for New England Compounding Center. State board of pharmacy records for Massachusetts are not checked: the board’s website refused automated requests, and this index does not work around blocks. The California State Board of Pharmacy’s posted disciplinary decisions on facility licenses also lists 2 actions: “Through a disciplinary action of the board, the license is voluntarily surrendered” dated Sep 16, 2013, case AC 4451 on nonresident license NRP 586 and “Through a disciplinary action of the board, the license is voluntarily surrendered” dated Sep 16, 2013, case AC 4451 on nonresident license NSC 99216. The Colorado State Board of Pharmacy’s license dataset also lists 3 actions: “CLS Voluntary Surrender/Relinquishment” dated Apr 8, 2013, case 2012-6062 on nonresident license OSP 5402, “CLS Suspension” dated Oct 12, 2012, case 2012-6062 on nonresident license OSP 5402 and “CLS Stipulation” dated Oct 12, 2012, case 2012-6062 on nonresident license OSP 5402. The Board of Pharmacy section of the Tennessee Department of Health’s monthly Disciplinary Action Reports also lists “License voluntarily surrendered/revoked” dated October 2012. The Illinois Department of Financial and Professional Regulation’s license dataset also lists “Suspension” dated Oct 18, 2012, case 2012010295 on nonresident license 054016977. The Maryland Board of Pharmacy’s posted orders against permit holders also lists “ORDER FOR SUMMARY SUSPENSION” dated Oct 5, 2012 on nonresident permit P03113.

FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.

Names in FDA records
New England Compounding Center
Location
Framingham, MA
Type as FDA labels it
503A
FDA 503B list
No matching record found
Form 483s on FDA’s actions page
0
Warning letters on FDA’s actions page
0
Latest action on that page
Jul 17, 2019
FDA Data Dashboard inspections
No matching site found
State board records
Not checked

FDA inspections and letters

FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as New England Compounding Center, a 503A facility, with 1 dated action.

Document
Jul 17, 2019OtherUnlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center (7/17/2019)FDA copy (archived)

FDA inspection classifications and published Form 483s

No inspected site under this exact name and city was found in the FDA Data Dashboard on Nov 15, 2026, searching 12,593 US sites with a drug inspection ending Oct 1, 2008 to Oct 23, 2026. FDA may list the site under another legal name, so this is not a finding that it was never inspected.

State board of pharmacy records

State board of pharmacy records for Massachusetts are not checked: the board’s website refused automated requests, and this index does not work around blocks.

Nonresident licenses and board actions in other states

These boards list a nonresident license or a board action whose record names this pharmacy’s own name, city and state.

Texas State Board of Pharmacy, file dated Nov 15, 2026 (Texas).

LicenseType as the board gives itName on the board recordLocationStatusPrior disciplinary orders (file flag)
22866Non-Resident (Not Located in Texas)NEW ENGLAND COMPOUNDING CENTERFRAMINGHAM, MARevocationYes

California State Board of Pharmacy, file dated Nov 6, 2026 (California).

Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).

LicenseType as the board gives itName on the board recordLocationStatus
OSP 5402OSPNew England Compounding CenterFRAMINGHAM, MASurrendered

Tennessee Board of Pharmacy, board actions read Nov 15, 2026 (Tennessee).

Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).

LicenseType as the board gives itName on the board recordLocationStatus
054016977LICENSED PHARMACYNEW ENGLAND COMPOUNDING CENTERFRAMINGHAM, MASUSPENDED
058013496LICENSED DIVISION II PHARMACYNEW ENGLAND COMPOUNDING CENTERFRAMINGHAM, MACANCELLED

Maryland Board of Pharmacy, board actions read Nov 15, 2026 (Maryland).

This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.

Sources

Records last pulled Nov 15, 2026. Every entry links to the original public record.